Hostname: page-component-5b777bbd6c-rbv74 Total loading time: 0 Render date: 2025-06-18T12:46:24.798Z Has data issue: false hasContentIssue false
  • English
  • Français

Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma

Published online by Cambridge University Press:  03 April 2025

Chang Woo Lee Open the ORCID record for Chang Woo Lee [Opens in a new window] ,
Wei Jia ,
Roanna Norman ,
Alex Dando ,
Susan Swain ,
Francesca Hilder ,
Maxine Flubacher ,
Joseph Davies ,
Oliver Donnelly  and
Jon Bird
...Show all authors
Chang Woo Lee*
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Wei Jia
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Roanna Norman
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Alex Dando
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Susan Swain
Affiliation:
Department of Speech and Language Therapy, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Francesca Hilder
Affiliation:
Department of Speech and Language Therapy, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Maxine Flubacher
Affiliation:
Department of Oncology, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Joseph Davies
Affiliation:
Department of Oncology, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Oliver Donnelly
Affiliation:
Department of Oncology, University Hospitals Dorset NHS Foundation Trust, Poole, UK Department of Oncology, Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Portsmouth, UK
Jon Bird
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Neil De Zoysa
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
Emma King
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Dorset NHS Foundation Trust, Poole, UK
*
Corresponding author: Chang Woo Lee; Email: changwoo.lee@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

Oncological and functional outcomes for T1-2 N0-1 (TNMv8) p16-positive oropharyngeal squamous cell carcinoma patients were analysed according to treatment: either transoral robotic surgery (TORS) (Surgery group – TORS and neck dissection ± adjuvant radiotherapy/chemoradiotherapy) or primary radiotherapy/chemoradiotherapy (Oncology group).

Methods

Single-centre retrospective observational study.

Results

The two-year disease-free survival rate was 88 per cent for the Oncology group (n = 42) and 95 per cent for the Surgery group (n = 44). The two-year overall survival rate was 98 per cent for the Oncology group and 100 per cent for the Surgery group. The functional swallowing outcome at two years post-treatment was similar in both groups. Subgroup analysis showed patients treated with surgery-only with no adjuvant treatment had the best functional outcome whilst patients treated with surgery and post-operative chemoradiotherapy had the worst functional outcome.

Conclusion

The overall oncological and functional outcomes at two years were similar in both groups. Patients treated with surgery-only had the best functional outcome without compromised oncological outcome.

Keywords

head and neck cancerhead and neck surgeryoncologyoropharynxswallowing
Type
Main Article
Information
The Journal of Laryngology & Otology , First View , pp. 1 - 8
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Chang Woo Lee takes responsibility for the integrity of the content of the paper

References

Mehanna, H, Beech, T, Nicholson, T, El-Hariry, I, McConkey, C, Paleri, V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747–55Google Scholar
Ang, KK, Harris, J, Wheeler, R, Weber, R, Rosenthal, DI, Nguyen-Tân, PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35Google Scholar
Ringash, J. Survivorship and quality of life in head and neck cancer. J Clin Oncol 2015;33:3322–7Google Scholar
Cracchiolo, JR, Baxi, SS, Morris, LG, Ganly, I, Patel, SG, Cohen, MA, et al. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base. Cancer 2016;122:1523–32Google Scholar
Homer, JJ, Winter, SC, Abbey, EC, Aga, H, Agrawal, R, Ap, Dafydd D, et al. Head and neck cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition. J Laryngol Otol 2024;138:S1–224Google Scholar
Yeh, DH, Tam, S, Fung, K, MacNeil, SD, Yoo, J, Winquist, E, et al. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - a systematic review of the literature. Eur J Surg Oncol 2015;41:1603–14Google Scholar
Owadally, W, Hurt, C, Timmins, H, Parsons, E, Townsend, S, Patterson, J, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer 2015;15:602Google Scholar
Ferris, RL, Flamand, Y, Weinstein, GS, Li, S, Quon, H, Mehra, R, et al. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol 2022;40:138–49Google Scholar
Lin, C, Sharbel, DD, Topf, MC. Surgical clinical trials for HPV-positive oropharyngeal carcinoma. Front Oncol 2022;12:992348Google Scholar
Nichols, AC, Theurer, J, Prisman, E, Read, N, Berthelet, E, Tran, E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol 2019;20:1349–59Google Scholar
Nichols, AC, Theurer, J, Prisman, E, Read, N, Berthelet, E, Tran, E, et al. Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR Trial. J Clin Oncol 2022;40:866–75Google Scholar
AJCC. AJCC Cancer Staging Manual. 8th ed. Springer International Publishing; 2017Google Scholar
Crary, MA, Mann, GD, Groher, ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 2005;86:1516–20Google Scholar
O’Malley, BW Jr, Weinstein, GS, Snyder, W, Hockstein, NG. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006;116:1465–72Google Scholar
Weinstein, GS, O’Malley, BW Jr, Snyder, W, Sherman, E, Quon, H. Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 2007;133:1220–6Google Scholar
de Almeida, JR, Byrd, JK, Wu, R, Stucken, CL, Duvvuri, U, Goldstein, DP, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope 2014;124:2096–102Google Scholar
AJCC. AJCC Cancer Staging Manual. 7th ed. Springer International Publishing; 2010Google Scholar
Amin, DR, Philips, R, Bertoni, DG, Mastrolonardo, EV, Campbell, DJ, Agarwal, AM, et al. Differences in functional and survival outcomes between patients receiving primary surgery vs chemoradiation therapy for treatment of T1-T2 oropharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2023;149:980–6Google Scholar
Chen, AY, Frankowski, R, Bishop-Leone, J, Hebert, T, Leyk, S, Lewin, J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127:870–6Google Scholar
Campo, F, Iocca, O, De, Virgilio A, Mazzola, F, Mercante, G, Pichi, B, et al. Treatment of oropharyngeal squamous cell carcinoma: is swallowing quality better after TORS or RT? Radiother Oncol 2023;183:109547Google Scholar
Achim, V, Bolognone, RK, Palmer, AD, Graville, DJ, Light, TJ, Li, R, et al. Long-term functional and quality-of-life outcomes after transoral robotic surgery in patients with oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg 2018;144:18–27Google Scholar
Poupore, NS, Chen, T, Nguyen, SA, Nathan, C-AO, Newman, JG. Transoral robotic surgery for oropharyngeal squamous cell carcinoma of the tonsil versus base of tongue: a systematic review and meta-analysis. Cancers (Basel) 2022;14:3837Google Scholar
King, SN, Dunlap, NE, Tennant, PA, Pitts, T. Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia 2016;31:339–51Google Scholar
Patterson, JM, McColl, E, Carding, PN, Wilson, JA. Swallowing beyond six years post (chemo)radiotherapy for head and neck cancer; a cohort study. Oral Oncol 2018;83:53–8Google Scholar
Tengku, S, Lohi, I, Connelly, A, Slaven, E, Sloane, K, Herity, K, et al. Late-onset swallowing outcomes post-treatment for head and neck cancer in a UK-based population. J Laryngol Otol 2023;137:293–300Google Scholar